BMRN has been granted a new patent
Dec 25, 2024, 11:31 PM
-6.66%
What does BMRN do
BioMarin Pharmaceutical, headquartered in San Rafael, California, develops therapies for serious rare diseases and employs 3,401 people. Its products include Vimizim, Roctavian, and Voxzogo for various medical conditions.
BMRN filed a patent for "high throughput screen for genetic variants associated with short stature" on Wed, June 7, 2023.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.